These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23576690)

  • 21. Molecular biology of esophageal cancer.
    Metzger R; Schneider PM; Warnecke-Eberz U; Brabender J; Hölscher AH
    Onkologie; 2004 Apr; 27(2):200-6. PubMed ID: 15138356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma.
    Rajendra S; Wang B; Snow ET; Sharma P; Pavey D; Merrett N; Ball MJ; Brain T; Fernando R; Robertson IK
    Am J Gastroenterol; 2013 Jul; 108(7):1082-93. PubMed ID: 23588239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Still waiting for predictive biomarkers in Barrett's oesophagus.
    Moyes LH; Going JJ
    J Clin Pathol; 2011 Sep; 64(9):742-50. PubMed ID: 21606229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.
    Hinton J; Callan R; Bodine C; Glasgow W; Brower S; Jiang SW; Li J
    Expert Rev Mol Diagn; 2013 Jun; 13(5):431-43. PubMed ID: 23782251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the risk of adenocarcinoma in Barrett's esophagus by means of tumor markers (p53 and Ki67).
    Trakál E; Guidi A; Butti AL; Trakál JJ; Sambuelli R; Zárate FE
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):211-5. PubMed ID: 21049770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel diagnostic and prognostic biomarkers in esophageal cancer.
    Plum PS; Bollschweiler E; Hölscher AH; Warnecke-Eberz U
    Expert Opin Med Diagn; 2013 Nov; 7(6):557-71. PubMed ID: 24093836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
    Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
    Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic evaluation of the patient with esophageal carcinoma.
    Boyce GA
    Chest Surg Clin N Am; 1994 May; 4(2):257-68. PubMed ID: 8049995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria.
    Aichler M; Elsner M; Ludyga N; Feuchtinger A; Zangen V; Maier SK; Balluff B; Schöne C; Hierber L; Braselmann H; Meding S; Rauser S; Zischka H; Aubele M; Schmitt M; Feith M; Hauck SM; Ueffing M; Langer R; Kuster B; Zitzelsberger H; Höfler H; Walch AK
    J Pathol; 2013 Aug; 230(4):410-9. PubMed ID: 23592244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; van Zoest KP; Moons LM; Hansen B; Pot RG; Siersema PD; Kusters JG; Kuipers EJ
    Scand J Gastroenterol; 2012 Apr; 47(4):378-86. PubMed ID: 22243485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative glycomic profiling in esophageal adenocarcinoma.
    Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomics study of esophageal adenocarcinoma.
    Zhang J; Liu L; Wei S; Nagana Gowda GA; Hammoud Z; Kesler KA; Raftery D
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):469-75, 475.e1-4. PubMed ID: 20880550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How far to go? Screening and surveillance in Barrett's esophagus.
    Lieberman DA; Sampliner RE
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in biomarkers for esophageal cancer.
    Nagaraja V; Eslick GD
    Expert Rev Anticancer Ther; 2013 Oct; 13(10):1169-80. PubMed ID: 24134419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma.
    Li Z; Yao Q; Zhao S; Wang Z; Li Y
    Artif Intell Med; 2017 Feb; 76():1-6. PubMed ID: 28363284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomics of Esophageal Cancer and Biomarkers for Early Detection.
    Pusung M; Zeki S; Fitzgerald R
    Adv Exp Med Biol; 2016; 908():237-63. PubMed ID: 27573775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma.
    Antonowicz S; Bodai Z; Wiggins T; Markar SR; Boshier PR; Goh YM; Adam ME; Lu H; Kudo H; Rosini F; Goldin R; Moralli D; Green CM; Peters CJ; Habib N; Gabra H; Fitzgerald RC; Takats Z; Hanna GB
    Nat Commun; 2021 Mar; 12(1):1454. PubMed ID: 33674602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early esophageal cancer screening in China.
    Gao QY; Fang JY
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):885-93. PubMed ID: 26651250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using saliva epigenetic data to develop and validate a multivariable predictor of esophageal cancer status.
    Stone TC; Ward V; Hogan A; Ho KMA; Wilson A; McBain H; Duku M; Wolfson P; Cheung S; Rosenfeld A; Lovat LB;
    Epigenomics; 2024 Jan; 16(2):109-125. PubMed ID: 38226541
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk prediction models for esophageal cancer: A systematic review and critical appraisal.
    Li H; Sun D; Cao M; He S; Zheng Y; Yu X; Wu Z; Lei L; Peng J; Li J; Li N; Chen W
    Cancer Med; 2021 Oct; 10(20):7265-7276. PubMed ID: 34414682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.